Literature DB >> 1001049

Echocardiographic manifestations of infiltrative cardiomyopathy. A report of seven cases due to amyloid.

J S Child, J A Levisman, A S Abbasi, R N MacAlpin.   

Abstract

Echocardiography has been useful in the evaluation of congestive and hypertrophic cardiomyopathies. We present echocardiographic findings in seven patients with infiltrative cardiomyopathy due to amyloid. Cardiac amyloidosis was documented at autopsy in two patients, and the diagnosis was suggested by clinical, echocardiographic, tissue, or hemodynamic findings in the other five. Hemodynamic findings in three patients mimicked constrictive pericarditis; and autopsy was performed on one of the three and showed a normal pericardium. Underlying disorders were multiple myeloma (five patients), ankylosing spondylitis (one patient), and an unknown disorder (one patient). The basic echocardiographic findings in infiltrative cardiomyopathy due to amyloid were (1) symmetrically increased left ventricular wall thickness (in the absence of hypertension or aortic valvular disease), (2) hypokinesia and decreased systolic thickening of the interventricular septum and left ventricular posterior wall, and (3) small to normal size of the left ventricular cavity. Two patients also had small pericardial effusions. Thus, in a patient with congestive heart failure, these echocardiographic findings should suggest infiltrative cardiomyopathy.

Entities:  

Mesh:

Year:  1976        PMID: 1001049     DOI: 10.1378/chest.70.6.726

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

Review 2.  Transthyretin Cardiac Amyloidosis in Black Americans.

Authors:  Keyur B Shah; Anit K Mankad; Adam Castano; Olakunle O Akinboboye; Phillip B Duncan; Icilma V Fergus; Mathew S Maurer
Journal:  Circ Heart Fail       Date:  2016-06       Impact factor: 8.790

Review 3.  Transthyretin Cardiac Amyloidosis.

Authors:  Anit K Mankad; Keyur B Shah
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

4.  Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy.

Authors:  Rahul Suresh; Martha Grogan; Joseph J Maleszewski; Patricia A Pellikka; Mazen Hanna; Angela Dispenzieri; Naveen L Pereira
Journal:  J Am Soc Echocardiogr       Date:  2014-01-18       Impact factor: 5.251

5.  Computed tomographic appearances of cardiac amyloidosis.

Authors:  T Sekiya; C J Foster; I Isherwood; S B Lucas; M K Kahn; J P Miller
Journal:  Br Heart J       Date:  1984-05

Review 6.  It Takes a Village: Multimodality Imaging of Cardiac Amyloidosis.

Authors:  Jean Michel Saad; Ahmed Ibrahim Ahmed; Dixitha Anugula; Yushui Han; Moath Said Alfawara; Mouaz H Al-Mallah
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-03-14

7.  Cardiac amyloidosis diagnosed by endomyocardial biopsy.

Authors:  M A Kim; C H Kim; B H Oh; Y B Park; Y S Choi; J D Seo; Y W Lee
Journal:  Korean J Intern Med       Date:  1988-07       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.